The article reflects on the history of the controversial substance polylaminate, drawing parallels with the infamous fosfoetanolamina, or "cancer pill," initially popularized by Gilberto Chierice of USP. This compound was promoted based on preliminary results without adequate clinical evidence, leading to its distribution among cancer patients despite lacking approval from health authorities. The subsequent fervor surrounding the substance overrode scientific reluctance, framing it as a national savior despite its irregular status.

In 2016, bolstered by public enthusiasm, the Brazilian Congress authorized the use of fosfoetanolamina, only for the Supreme Court to later declare it unconstitutional, emphasizing that public emotion cannot dictate regulatory approval. This legal setback prompted the emergence of similar but equally unregulated supplements, highlighting a troubling trend where demands for alternative treatments flourish in the absence of scientific endorsement.

The attention garnered by this situation is significant, even extending to international scientific circles like Nature and Science, which criticized it as a cautionary tale of the dangers of sidelining scientific rigor in favor of populist beliefs in miraculous cures. The broader implications suggest a growing challenge in balancing scientific integrity with public demand for quick medical solutions amidst the ongoing struggle against cancer.